On one hand, tumors have exploited NMD to downregulate key tumor-suppressor gene expression, whereas on the other hand, adjusted NMD activity to adapt to their microenvironment (Popp and Maquat, 2018). The gene discussed is PLA1A; the disease is neoplasm.